1 year return (CAGR)
42.74%
Allogene Therapeutics Inc Exchange (NASDAQ, USD)
ALLO
1.67
-0.04 (-2.34%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-24.56%
5 year return (CAGR)
-41.80%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
576.97M
Price/Sales
124.35
Ent value
652.26M
Price/Book
1.32
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-16.08%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.73 |
| Daily high | 1.74 |
| Daily low | 1.65 |
| Daily Volume | 5.90M |
| All-time high | 54.04 |
| 1y analyst estimate | 9.00 |
| Beta | 0.47 |
| EPS (TTM) | -0.50 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ALLO | S&P500 | |
| Current price drop from All-time high | -96.91% | -1.38% |
| Highest price drop | -98.24% | -56.47% |
| Date of highest drop | 14 May 2025 | 9 Mar 2009 |
| Avg drop from high | -66.98% | -10.68% |
| Avg time to new high | 154 days | 12 days |
| Max time to new high | 1592 days | 1805 days |
News
